JPMORGAN CHASE & CO - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 280 filers reported holding CONMED CORP in Q2 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$52,114,641
-61.1%
516,754
-47.6%
0.01%
-60.0%
Q2 2023$133,905,600
+27.0%
985,397
-2.9%
0.02%
+15.4%
Q1 2023$105,445,000
+130064.5%
1,015,245
+11.1%
0.01%
+18.2%
Q4 2022$81,009
-99.9%
913,894
+4.1%
0.01%
+10.0%
Q3 2022$70,398,000
-25.7%
878,110
-11.2%
0.01%
-23.1%
Q2 2022$94,722,000
-23.7%
989,166
+18.3%
0.01%
-13.3%
Q1 2022$124,215,000
+5.3%
836,181
+0.5%
0.02%
+7.1%
Q4 2021$117,915,000
+1.1%
831,784
-6.7%
0.01%0.0%
Q3 2021$116,610,000
+3.0%
891,307
+8.2%
0.01%0.0%
Q2 2021$113,253,000
+124.1%
824,073
+113.0%
0.01%
+100.0%
Q1 2021$50,533,000
+192.2%
386,957
+150.6%
0.01%
+133.3%
Q4 2020$17,295,000
+103.9%
154,425
+40.4%
0.00%
+200.0%
Q3 2020$8,484,000
+14.8%
110,016
+7.2%
0.00%0.0%
Q2 2020$7,390,000
+28.4%
102,671
+2.1%
0.00%0.0%
Q1 2020$5,757,000
-60.2%
100,519
-22.3%
0.00%
-66.7%
Q4 2019$14,469,000
+28.7%
129,383
+10.7%
0.00%
+50.0%
Q3 2019$11,240,000
+13.8%
116,895
+1.1%
0.00%0.0%
Q2 2019$9,874,000
-23.8%
115,660
-25.8%
0.00%
-33.3%
Q1 2019$12,964,000
+85.0%
155,854
+42.8%
0.00%
+50.0%
Q4 2018$7,008,000
+6.5%
109,158
+31.4%
0.00%
+100.0%
Q3 2018$6,582,000
-6.4%
83,099
-13.5%
0.00%0.0%
Q2 2018$7,034,000
+96.4%
96,091
+69.9%
0.00%0.0%
Q1 2018$3,581,000
-15.6%
56,543
-32.1%
0.00%0.0%
Q4 2017$4,245,000
+397.7%
83,297
+412.8%
0.00%
Q3 2017$853,000
-43.0%
16,245
-44.7%
0.00%
Q2 2017$1,496,000
+208.5%
29,361
+169.0%
0.00%
Q1 2017$485,000
-84.9%
10,916
-85.0%
0.00%
-100.0%
Q4 2016$3,214,000
+21326.7%
72,769
+18949.5%
0.00%
Q3 2016$15,000
-99.4%
382
-99.2%
0.00%
-100.0%
Q2 2016$2,404,000
+20.0%
50,366
+5.5%
0.00%0.0%
Q1 2016$2,003,000
-2.8%
47,753
+2.1%
0.00%0.0%
Q4 2015$2,060,000
-8.1%
46,758
-0.4%
0.00%0.0%
Q3 2015$2,242,000
-67.2%
46,962
-60.0%
0.00%
-50.0%
Q2 2015$6,835,000
+21.4%
117,306
+5.2%
0.00%
+100.0%
Q1 2015$5,629,000
-19.4%
111,487
-28.2%
0.00%
-50.0%
Q4 2014$6,981,000
+23.1%
155,262
+0.9%
0.00%
+100.0%
Q3 2014$5,670,000
-46.3%
153,911
-35.6%
0.00%
-66.7%
Q2 2014$10,552,000
+2.9%
239,042
+1.3%
0.00%0.0%
Q1 2014$10,256,000
+27.2%
236,011
+24.4%
0.00%
+50.0%
Q4 2013$8,060,000
+19.0%
189,670
-4.9%
0.00%0.0%
Q3 2013$6,772,000
+30.1%
199,397
+19.7%
0.00%0.0%
Q2 2013$5,205,000166,5840.00%
Other shareholders
CONMED CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Iron Triangle Partners LP 217,204$29,850,0003.08%
Ranger Investment Management 260,524$35,804,0001.87%
EARNEST PARTNERS LLC 1,628,848$223,853,0001.32%
Penn Capital Management Company, LLC 87,232$11,988,0001.16%
DeepCurrents Investment Group LLC 257,334$35,365,0001.06%
Champlain Investment Partners, LLC 1,475,989$202,845,0000.96%
Hood River Capital Management LLC 224,050$30,791,0000.92%
OAK RIDGE INVESTMENTS LLC 74,178$10,194,0000.89%
MOODY ALDRICH PARTNERS LLC 45,667$6,276,0000.88%
WAFRA INC. 138,542$19,040,0000.72%
View complete list of CONMED CORP shareholders